BioSpace News Archive

Patients in communities across the United States will reap the benefits of 3D mammography with new installations.

PharmaCyte Biotech, Inc., Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its 6-month study on storage of the frozen encapsulated cells necessary for the determination of an “initial shelf life” has been successfully completed by Austrianova.

FIRST® (For Inspiration and Recognition of Science and Technology), an international K-12 not-for-profit organization founded by inventor Dean Kamen, today announced a $1.5 million grant awarded by The Boeing Company to support young innovators through FIRST programming.

Study in The Journal of the American Osteopathic Association Suggests Up to 50 Percent of U.S. Population is Magnesium Deficient

Two-day conference draws cardiac electrophysiology experts from across the globe

Solution offers researchers increased sensitivity without sacrificing robustness or usability

The Biotechnology Innovation Organization (BIO) today announced the selection of Des Moines, Iowa, as the location for the 2019 BIO World Congress on Industrial Biotechnology.

RenovaCare, Inc., (RCAR), developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, today announced new initiatives to expand its product pipeline and associated clinical indications beyond severe second-degree burns.

NuVasive, Inc. announced today financial results for the quarter and full year ended Dec. 31, 2017.